Use of a bacterial lysate to treat atopic dermatitis

摘要

A bacterial lysate derived from at least one of the following strains: Haemophilus influenzae, serotype B NCTC 8467 Diplococcus pneumoniae, serotypes 1, 2, 3 and 47 NCTC 7465, 7466, 7978 and 10319 Klebsiella pneumoniae NCTC 204 and 5056 Klebsiella ozaenae NCTC 5050 Staphylococcus aureus I-049, I-050, I-051, I-052, I-053, and I-054 Streptococcus viridans I-046, I-047 and I-048 Treptococcus pyogenes, group A NCTC 8191 Branhamella catarrhalis (formerly Neisseria catarrhalis) I-045, NCTC 3622 and 3625 is used to manufacture a drug for treating atopic dermatitis.